Authors:
Pizer, ES
Pflug, BR
Bova, GS
Han, WF
Udan, MS
Nelson, JB
Citation: Es. Pizer et al., Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression, PROSTATE, 47(2), 2001, pp. 102-110
Authors:
Bova, GS
Parmigiani, G
Epstein, JI
Wheeler, T
Mucci, NR
Rubin, MA
Citation: Gs. Bova et al., Web-based tissue microarray image data analysis: Initial validation testing through prostate cancer Gleason grading, HUMAN PATH, 32(4), 2001, pp. 417-427
Citation: J. Pinski et al., Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts, CANCER RES, 61(17), 2001, pp. 6372-6376
Authors:
Lin, XH
Tascilar, M
Lee, WH
Vles, WJ
Lee, BH
Veeraswamy, R
Asgari, K
Freije, D
van Rees, B
Gage, WR
Bova, GS
Isaacs, WB
Brooks, JD
DeWeese, TL
De Marzo, AM
Nelson, WG
Citation: Xh. Lin et al., GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells, AM J PATH, 159(5), 2001, pp. 1815-1826
Authors:
Kinoshita, H
Shi, Y
Sandefur, C
Meisner, LF
Chang, CS
Choon, A
Reznikoff, CR
Bova, GS
Friedl, A
Jarrard, DF
Citation: H. Kinoshita et al., Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer, CANCER RES, 60(13), 2000, pp. 3623-3630
Authors:
Su, GH
Hruban, RH
Bansal, RK
Bova, GS
Tang, DJ
Shekher, MC
Westerman, AM
Entius, MM
Goggins, M
Yeo, CJ
Kern, SE
Citation: Gh. Su et al., Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers, AM J PATH, 154(6), 1999, pp. 1835-1840
Authors:
Kibel, AS
Schutte, M
Kern, SE
Isaacs, WB
Bova, GS
Citation: As. Kibel et al., Identification of 12p as a region of frequent deletion in advanced prostate cancer, CANCER RES, 58(24), 1998, pp. 5652-5655